OR WAIT null SECS
January 31, 2014
With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.
September 01, 2013
A CMO perspective on the CMO-client partnership.
June 02, 2013
Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.
February 02, 2013
Is the contract-only CMO an endangered species?
November 02, 2012
Key talks from the recent PDA/FDA regulatory conference highlight room for improvement.
August 01, 2012
Annual survey shows strong growth for service providers and promises to continue into 2013.
March 02, 2012
The evolving bio/pharmaceutical business model poses risk for CMOs.
August 02, 2006
Contract service providers should be concerned about the market perceptions of their performance.
February 02, 2005
Too many players and threats to the main customer base challenge European dose manufacturers.
January 02, 2005
Patheon is betting the whole is worth more than the sum of the parts in its acquisition of Puerto Rico contract manufacturer Mova.